Latest / frontpage / frontpage: sun sep 20

Transcript

frontpage: sun sep 20 · frontpage

• 0:00
  Host 1: Welcome to your front page deep dive for Sunday, September 20th, 2026. M4A
• 0:03
  Host 1: Let's get right into today's major papers. M4A
• 0:05
  Host 2: Yeah, there's uh, there's quite a lot to unpack this morning. M4A
• 0:08
  Host 1: There really is. M4A
• 0:09
  Host 1: Today, we're tracking this fascinating through line across the New York Times, M4A
• 0:13
  Host 1: the LA Times and the Washington Post. M4A
• 0:15
  Host 1: And the core theme we're seeing is this striking contrast. M4A
• 0:18
  Host 2: Right, the contrast between the top and the bottom. M4A
• 0:20
  Host 1: Exactly, you have these massive, sweeping executive policy decisions M4A
• 0:24
  Host 1: happening at the very top. M4A
• 0:25
  Host 2: And then you see the intense, totally unpredictable ripple effects M4A
• 0:28
  Host 2: on local communities, on state institutions, and you know, on individual lives. M4A
• 0:32
  Host 1: Yeah, because we're looking at how these macro-level decisions in Washington, M4A
• 0:36
  Host 1: or on the global stage, ultimately show up right on your doorstep. M4A
• 0:39
  Host 2: Mhm, or you know, in your wallet, or on your screens. M4A
• 0:41
  Host 1: It really shatters the illusion that national policy is just this M4A
• 0:44
  Host 1: abstract chess game played in a vacuum. M4A
• 0:46
  Host 1: So, let's start at the highest level of national politics right now. M4A
• 0:49
  Host 1: The reality of executive action is basically crashing into the practical mechanics M4A
• 0:53
  Host 1: of getting re-elected. M4A
• 0:54
  Host 2: Right, the mid-term calculus. M4A
• 0:56
  Host 1: Yes. The Washington Post has this great reporting today. M4A
• 0:59
  Host 1: Publicly, President Trump is expressing, you know, total confidence. M4A
• 1:02
  Host 2: Sure, as always. M4A
• 1:04
  Host 1: Right, but privately... M4A
• 1:05
  Host 1: The Post reports that he's actually realized his decisions on the Iran war M4A
• 1:09
  Host 1: are contributing to a pretty dire mid-term picture for Republicans. M4A
• 1:12
  Host 2: Yeah, his aides are apparently presenting him with some really discouraging polling, M4A
• 1:16
  Host 2: and that's prompting him to open up his war chest, right? M4A
• 1:19
  Host 2: He's having to spend to mitigate the damage. M4A
• 1:21
  Host 1: Exactly. M4A
• 1:22
  Host 1: And then you look at the LA Times, and they show exactly how this M4A
• 1:25
  Host 1: is playing out locally. M4A
• 1:27
  Host 1: Like, on the ground in California. M4A
• 1:29
  Host 2: Oh, the political jiu-jitsu. M4A
• 1:31
  Host 1: Yes. M4A
• 1:32
  Host 1: Rob Stutzman, the GOP consultant, called it political jiu-jitsu. M4A
• 1:35
  Host 1: California Republicans in these really tight House races are actively skipping M4A
• 1:39
  Host 1: Trump's Dallas convention. M4A
• 1:41
  Host 2: Wow. Just skipping it entirely? M4A
• 1:43
  Host 1: Entirely. M4A
• 1:44
  Host 1: And they're quietly removing his name from their campaign websites to woo swing voters. M4A
• 1:48
  Host 2: Meanwhile, Trump is at his rallies telling crowds, you know, M4A
• 1:51
  Host 2: 'you have to pretend I am on the ticket.' M4A
• 1:53
  Host 1: Right. Okay, let's unpack this for a second. M4A
• 1:56
  Host 1: Because it's kind of like a corporate rebrand, right? M4A
• 1:58
  Host 2: Okay, I like that analogy. M4A
• 2:00
  Host 1: It's like the local franchise managers are desperately trying to hide M4A
• 2:04
  Host 1: the parent company's controversial logo. M4A
• 2:06
  Host 1: They're scrubbing it off the doors just to keep the regular customers coming in. M4A
• 2:09
  Host 2: Yeah. M4A
• 2:10
  Host 2: But the CEO is on television demanding that everyone paint it on the roof. M4A
• 2:14
  Host 1: It's a massive disconnect, and you really have to wonder how sustainable M4A
• 2:17
  Host 1: that strategy is when the economic impacts are so tangible. M4A
• 2:20
  Host 1: Which brings us to the New York Times piece. M4A
• 2:23
  Host 2: Yeah. Because the economic side of this balancing act is wild. M4A
• 2:26
  Host 1: Senator Dan Sullivan, the Republican from Alaska. M4A
• 2:28
  Host 2: You have this intense pressure for national party loyalty, but it's totally colliding M4A
• 2:32
  Host 2: with localized economic and political survival. M4A
• 2:35
  Host 1: Right, 'cause tariffs dictate the cost of raw materials. M4A
• 2:37
  Host 1: So the senator's own family business is being squeezed by the policies M4A
• 2:41
  Host 1: he has to support in Washington. M4A
• 2:43
  Host 2: It's incredible. M4A
• 2:44
  Host 2: And you know, that economic leverage we're seeing in the tariff debate, M4A
• 2:47
  Host 2: it extends directly into how the administration is gripping health and scientific institutions right now. M4A
• 2:51
  Host 1: Oh definitely. Let's pivot to that. M4A
• 2:53
  Host 1: Because the Washington Post has this FOIA reporting... M4A
• 2:55
  Host 1: Freedom of Information Act reporting on the administration's drug deals M4A
• 2:58
  Host 1: with Pfizer and Eli Lilly. M4A
• 3:00
  Host 2: This was a huge story. M4A
• 3:02
  Host 1: Yeah. M4A
• 3:03
  Host 1: There's a document from September 2025 signed by Pfizer CEO Albert Bourla M4A
• 3:06
  Host 1: and HHS Secretary RFK Jr. M4A
• 3:08
  Host 2: And this reveals the confidential terms of those deals, right? M4A
• 3:11
  Host 1: Right. M4A
• 3:12
  Host 1: So to lower US drug prices, the administration offered these pharma companies M4A
• 3:15
  Host 1: tariff protections. M4A
• 3:17
  Host 2: Mhm. M4A
• 3:18
  Host 2: And actual inducements to raise their drug prices overseas. M4A
• 3:20
  Host 1: Wow. M4A
• 3:22
  Host 1: And all of this was hidden behind broad confidentiality clauses M4A
• 3:25
  Host 1: that exempted them from FOIA. M4A
• 3:27
  Host 2: So they essentially squeezed a balloon. M4A
• 3:29
  Host 1: How do you mean? M4A
• 3:31
  Host 2: Well, you know, if you force the air out on the US side M4A
• 3:34
  Host 2: to get those prices down... M4A
• 3:36
  Host 1: It just pops right up on the overseas side. M4A
• 3:38
  Host 2: Exactly. M4A
• 3:39
  Host 1: Here's where it gets really interesting to me though. M4A
• 3:41
  Host 2: Mhm. M4A
• 3:42
  Host 1: If lowering drug prices is this massive political win, why bury the actual mechanics M4A
• 3:46
  Host 1: of it in broad confidentiality agreements? M4A
• 3:48
  Host 2: Well, because it reveals a really profound centralization of executive power. M4A
• 3:52
  Host 1: Right. M4A
• 3:53
  Host 2: They're using federal leverage to quietly reshape global market dynamics. M4A
• 3:56
  Host 2: I mean, forcing European or Asian markets to essentially subsidize American pharmacies M4A
• 4:00
  Host 2: is geopolitically explosive. M4A
• 4:01
  Host 1: Obviously. M4A
• 4:02
  Host 2: Yeah. M4A
• 4:03
  Host 2: And they're using that same kind of quiet structural leverage internally, too. M4A
• 4:07
  Host 1: The Post covers this massive clash in the Oval Office over the National Institutes of Health. M4A
• 4:11
  Host 2: The NIH, yeah, with their 47 billion dollar budget. M4A
• 4:13
  Host 1: Exactly. M4A
• 4:14
  Host 1: White House budget chief Russell Vought is pushing to restrict NIH grants M4A
• 4:18
  Host 1: that he personally deems, quote, 'woke'. M4A
• 4:20
  Host 2: And this follows previous cuts they made to minority, gay, transgender, M4A
• 4:23
  Host 2: and women's health research. M4A
• 4:25
  Host 1: Right. M4A
• 4:26
  Host 1: So now, the NIH director, Jay Bhattacharya, is actively defending M4A
• 4:30
  Host 1: the agency's grant-making process. M4A
• 4:32
  Host 2: Because normally, this is done through peer review. M4A
• 4:34
  Host 1: Right, it's independent scientists. M4A
• 4:36
  Host 1: But Vought is pushing for an executive order commission to oversee it instead. M4A
• 4:40
  Host 2: So he wants to bypass the scientists entirely. M4A
• 4:42
  Host 1: Exactly. M4A
• 4:43
  Host 1: He's trying to ideologically filter scientific research. M4A